Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Pathophysiology and treatment of inflammatory anorexia in chronic disease.

Braun TP, Marks DL.

J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):135-145. Epub 2010 Dec 17.

2.

Central nervous system mechanisms contributing to the cachexia-anorexia syndrome.

Plata-Salamán CR.

Nutrition. 2000 Oct;16(10):1009-12. Review.

PMID:
11054608
3.

[Recent development in research and management of cancer anorexia-cachexia syndrome].

Inui A.

Gan To Kagaku Ryoho. 2005 Jun;32(6):743-9. Review. Japanese.

PMID:
15984510
4.

Mechanisms of Anorexia Cancer Cachexia Syndrome and Potential Benefits of Traditional Medicine and Natural Herbs.

Ming-Hua C, Bao-Hua Z, Lei Y.

Curr Pharm Biotechnol. 2016;17(13):1147-1152. Review.

PMID:
27758689
5.

Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.

Koehler F, Doehner W, Hoernig S, Witt C, Anker SD, John M.

Int J Cardiol. 2007 Jun 25;119(1):83-9. Epub 2006 Oct 24.

PMID:
17064790
6.

Update on melanocortin interventions for cachexia: progress toward clinical application.

DeBoer MD.

Nutrition. 2010 Feb;26(2):146-51. doi: 10.1016/j.nut.2009.07.003. Epub 2009 Dec 8. Review.

7.

Neuropeptides in the pathophysiology and treatment of cachexia.

Krasnow SM, Marks DL.

Curr Opin Support Palliat Care. 2010 Dec;4(4):266-71. doi: 10.1097/SPC.0b013e32833e48e7. Review.

8.

[Pathogenesis and treatment of cancer anorexia-cachexia, with special emphasis on aged patients].

Inui A.

Nihon Ronen Igakkai Zasshi. 2004 Sep;41(5):460-7. Review. Japanese.

PMID:
15515719
9.

Progesterone therapy for the treatment of non-cancer cachexia: a systematic review.

Taylor JK, Pendleton N.

BMJ Support Palliat Care. 2016 Sep;6(3):276-86. doi: 10.1136/bmjspcare-2015-001041. Epub 2016 Apr 20. Review.

PMID:
27098973
10.

The role of ghrelin in anorexia-cachexia syndromes.

Guillory B, Splenser A, Garcia J.

Vitam Horm. 2013;92:61-106. doi: 10.1016/B978-0-12-410473-0.00003-9. Review.

PMID:
23601421
11.

Leptin in anorexia and cachexia syndrome.

Engineer DR, Garcia JM.

Int J Pept. 2012;2012:287457. doi: 10.1155/2012/287457. Epub 2012 Feb 8.

12.

[Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].

Inui A.

Rinsho Byori. 2006 Oct;54(10):1044-51. Review. Japanese.

PMID:
17133993
14.

Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.

Xu B, Dube MG, Kalra PS, Farmerie WG, Kaibara A, Moldawer LL, Martin D, Kalra SP.

Endocrinology. 1998 Feb;139(2):466-73.

PMID:
9449612
15.

The origins of cachexia in acute and chronic inflammatory diseases.

Delano MJ, Moldawer LL.

Nutr Clin Pract. 2006 Feb;21(1):68-81. Review.

PMID:
16439772
16.

Guidelines for the use of orexigenic drugs in long-term care.

Thomas DR.

Nutr Clin Pract. 2006 Feb;21(1):82-7. Review.

PMID:
16439773
17.

Hypothalamic mechanisms in cachexia.

Grossberg AJ, Scarlett JM, Marks DL.

Physiol Behav. 2010 Jul 14;100(5):478-89. doi: 10.1016/j.physbeh.2010.03.011. Epub 2010 Mar 25. Review.

18.

Neuropeptide Y: a key molecule in anorexia and cachexia in wasting disorders?

Inui A.

Mol Med Today. 1999 Feb;5(2):79-85. Review.

PMID:
10200949
19.

The central role of hypothalamic inflammation in the acute illness response and cachexia.

Burfeind KG, Michaelis KA, Marks DL.

Semin Cell Dev Biol. 2016 Jun;54:42-52. doi: 10.1016/j.semcdb.2015.10.038. Epub 2015 Nov 3. Review.

20.

Neural control of the anorexia-cachexia syndrome.

Laviano A, Inui A, Marks DL, Meguid MM, Pichard C, Rossi Fanelli F, Seelaender M.

Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1000-8. doi: 10.1152/ajpendo.90252.2008. Epub 2008 Aug 19. Review.

Supplemental Content

Support Center